+ Follow NOVARTIS HEALTHCARE PHILIPPINES Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1344305
[Title] => Forum aims to strengthen partnerships for Phl healthcare
[Summary] => For the third consecutive year, Novartis Healthcare Philippines partnered with the Asian Institute of Management (AIM) and St. Luke’s Medical Center (SLMC) to gather government and private sector stakeholders and align their priorities in order to strengthen the Philippine healthcare system.
[DatePublished] => 2014-07-10 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Forum-Phl-healthcare.jpg
)
[1] => Array
(
[ArticleID] => 1344307
[Title] => Access program helps poor cancer patients get treatment
[Summary] => A patient support group has lauded Novartis Healthcare Philippines for its unprecedented access program that helps underprivileged patients get the cancer treatments they need.
[DatePublished] => 2014-07-10 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Max-Philippines-Novartis-Healthcare.jpg
)
[2] => Array
(
[ArticleID] => 1323092
[Title] => Novartis leads Thalassemia Day observance
[Summary] => Novartis Healthcare Philippines partnered with patient support group Balikatang Thalassemia (Ba-Tha) and the Quezon City Health Department to lead the country’s observance of World Thalassemia Day (WTD).
[DatePublished] => 2014-05-15 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 1305399
[Title] => Novartis, SLMC forge tie-up on eye diseases
[Summary] => Novartis Healthcare Philippines and the Eye Institute of St. Luke’s Medical Center (SLMC) have signed a memorandum of agreement (MOA) to enhance the diagnosis and treatment of blindness-causing eye diseases.
[DatePublished] => 2014-03-27 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 1305215
[Title] => Visually impaired Pinoys to hit over 2 M this year – study
[Summary] => More than two million Filipinos are projected to develop visual impairment this year due to various reasons, ranging from chronic illnesses to aging, an expert from the Philippine Academy of Opthalmology (PAO) said yesterday.
[DatePublished] => 2014-03-26 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[5] => Array
(
[ArticleID] => 1302772
[Title] => Novartis partners with PHC on clinical research
[Summary] => Novartis Healthcare Philippines and the Philippine Heart Center (PHC) have signed a memorandum of agreement (MOA) to establish a Center of Excellence for Clinical Trials that aims to enhance the hospital’s capabilities in conducting and participating in clinical trials that adhere to international ethical standards.
[DatePublished] => 2014-03-20 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 1297439
[Title] => Novartis, DOH vow to hasten progress in leprosy control
[Summary] => The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.
[DatePublished] => 2014-03-06 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 1284392
[Title] => Novartis, DOH lead country’s World Leprosy Day observance
[Summary] => The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.
[DatePublished] => 2014-01-30 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 1264146
[Title] => Drug tackles new challenges in kidney, liver transplants
[Summary] => A paradigm shift in kidney transplantation in the last decade has shifted the focus from preventing acute organ rejection to preventing chronic graft (transplanted kidney) dysfunction and mortality in transplant patients with functioning grafts.
[DatePublished] => 2013-12-05 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 1251174
[Title] => PhilHealth, Ateneo, Novartis partner anew on UHC
[Summary] => For the second consecutive year, the Philippine Health Insurance Corp. (PhilHealth), Ateneo School of Medicine and Public Health (ASMPH) and Novartis Healthcare Philippines have worked together to hold a multi-stakeholder policy forum on universal health care (UHC).
[DatePublished] => 2013-10-31 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
NOVARTIS HEALTHCARE PHILIPPINES
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1344305
[Title] => Forum aims to strengthen partnerships for Phl healthcare
[Summary] => For the third consecutive year, Novartis Healthcare Philippines partnered with the Asian Institute of Management (AIM) and St. Luke’s Medical Center (SLMC) to gather government and private sector stakeholders and align their priorities in order to strengthen the Philippine healthcare system.
[DatePublished] => 2014-07-10 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Forum-Phl-healthcare.jpg
)
[1] => Array
(
[ArticleID] => 1344307
[Title] => Access program helps poor cancer patients get treatment
[Summary] => A patient support group has lauded Novartis Healthcare Philippines for its unprecedented access program that helps underprivileged patients get the cancer treatments they need.
[DatePublished] => 2014-07-10 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] => http://media.philstar.com/images/the-philippine-star/business/science-and-technology/20140710/Max-Philippines-Novartis-Healthcare.jpg
)
[2] => Array
(
[ArticleID] => 1323092
[Title] => Novartis leads Thalassemia Day observance
[Summary] => Novartis Healthcare Philippines partnered with patient support group Balikatang Thalassemia (Ba-Tha) and the Quezon City Health Department to lead the country’s observance of World Thalassemia Day (WTD).
[DatePublished] => 2014-05-15 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 1305399
[Title] => Novartis, SLMC forge tie-up on eye diseases
[Summary] => Novartis Healthcare Philippines and the Eye Institute of St. Luke’s Medical Center (SLMC) have signed a memorandum of agreement (MOA) to enhance the diagnosis and treatment of blindness-causing eye diseases.
[DatePublished] => 2014-03-27 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 1305215
[Title] => Visually impaired Pinoys to hit over 2 M this year – study
[Summary] => More than two million Filipinos are projected to develop visual impairment this year due to various reasons, ranging from chronic illnesses to aging, an expert from the Philippine Academy of Opthalmology (PAO) said yesterday.
[DatePublished] => 2014-03-26 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[5] => Array
(
[ArticleID] => 1302772
[Title] => Novartis partners with PHC on clinical research
[Summary] => Novartis Healthcare Philippines and the Philippine Heart Center (PHC) have signed a memorandum of agreement (MOA) to establish a Center of Excellence for Clinical Trials that aims to enhance the hospital’s capabilities in conducting and participating in clinical trials that adhere to international ethical standards.
[DatePublished] => 2014-03-20 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 1297439
[Title] => Novartis, DOH vow to hasten progress in leprosy control
[Summary] => The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.
[DatePublished] => 2014-03-06 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 1284392
[Title] => Novartis, DOH lead country’s World Leprosy Day observance
[Summary] => The Department of Health (DOH) and research-based Swiss healthcare company Novartis have vowed to continue their partnership in order to speed up the country’s progress in leprosy control.
[DatePublished] => 2014-01-30 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 1264146
[Title] => Drug tackles new challenges in kidney, liver transplants
[Summary] => A paradigm shift in kidney transplantation in the last decade has shifted the focus from preventing acute organ rejection to preventing chronic graft (transplanted kidney) dysfunction and mortality in transplant patients with functioning grafts.
[DatePublished] => 2013-12-05 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 1251174
[Title] => PhilHealth, Ateneo, Novartis partner anew on UHC
[Summary] => For the second consecutive year, the Philippine Health Insurance Corp. (PhilHealth), Ateneo School of Medicine and Public Health (ASMPH) and Novartis Healthcare Philippines have worked together to hold a multi-stakeholder policy forum on universal health care (UHC).
[DatePublished] => 2013-10-31 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
January 30, 2014 - 12:00am
December 5, 2013 - 12:00am
October 31, 2013 - 12:00am
